Header Image


Their Words, Not Ours

I was really impressed with the congress organization and the audience who represented top biosimilars experts worldwide. I believe the event offered an excellent platform for sharing insights and points of views of the different stake holders from both the industry and the regulators’ sides. Would certainly want to participate next year.

Dr Mourad Farouk

Medical Director @ International Development

Thank you for a good experience with the PARADIGM Global Events…
very high level, very good Organization, we overpassed our expectatives, we will be pending for another congress related to pharmaceutical and biotech… we learned a lot, and i think that the content of agenda was state of the art, thank you again.

Salvador Berrios

ERP/ CRM / Product Configurator Manager

It was a pleasure presenting at this year’s conference and thank you very much for the excellent organization.

Robert Friesen

VP and Head, Biologics Research @ Janssen

Many thanks for your support at the Congress last week, I found the meeting extremely informative and the Paradigm team absolutely fantastic!

Costantino Congiatu

PhD, Senior Specialist, Regulatory Affairs

PGE organizes an International, high quality conference packed with highly relevant presentations by EMA biosimilar assessors, biosimilar developers and originators with a high degree of delegate interaction.

Richard Di Cicco

CEO @ Harvest Moon

Great conference, varied and very relevant material. Great speakers and organizers. Was worth attending. Looking forward to next year’s event

Dr. Hanane Cherif

Quality and Compliance Director

A very interesting conference. Comprehensive programme. Highly qualified speakers

Dr. David Uguen

Exec. Director, Voisin Consulting Life Sciences

Very useful knowledge exchange

Marcus Mreyen

Director @ Protagen Protein Services

Fantastic speakers, very informative event

Agnieszka Kulesca

Clinical Operations Manager @ Biovirtus Research Site

Very informative Conference.

Dr. Adrian Haines

Senior Principal senior Scientist @ Lonza Biologics

Great interactive discussion with experts in their field.

Dr. Fiona Greer

Global Director, SGS M-SCAN

The 2014 Biosimilars Global Congress stimulated collaborative discussion to facilitate advancing the science and medicine for biosimilar product access for patients

Dr. Nancy Martin

VP, Clinical Development, Hospira

The program is very informative, far more comprehensive than others of this type

Renita Rathinam

Lawyer, Sughrue Mion PLLC, Litigation

The event provided a lot of different point of views about the same topic (Biosimilars)

Gabriela Scarpa

Product Manager, Marketing, Janssen

Well moderated event, interesting presentations, comfortable location

Dr. Roberta Marcone

Analytical Development and GMP Section Manager, Patheon

Conference had topics stimulating the interest of everyone from the biosimilars novices to the experts – overall great conference

Priyanku Basu

Senior Analyst, BCG

Paradigm organizes a packed high quality agenda with high quality industry and EMA assessor speakers

Richard DiCicco

Chairman, Harvest Moon Pharmaceuticals USA

I was impressed with the organization of this event. I attend many conferences per year and find the organizers on site to be detached and not focus on good service to the delegates. This team was even providing weather forecast warning to ensure everyone was aware and made appropriate plans. Well Done.

Adriana E. Manzi

PhD, Managing Director, Atheln, Inc

The consistently high quality of international faculty was most impressive. It was also obvious that they were carefully chosen not only for their particular expertise but also for their ability to communicate the subject matter to clinical and non-clinical participants alike. As market access consultant for pharma clients of various sizes, I now feel much better prepared to explain the nuances & dynamics involved in bringing their products to market. In addition, I am in a much better position to intelligently advice my clients & help them set realistic expectations

Thomas Martin

Associate Vice President, VCGA - Quintiles